HEALTH - Drugs Online: Virus or Cure?
By Suzanne M. Smalley, National Journal
© National
Journal Group Inc.
Saturday, June 12, 1999
It was a Sunday morning and Dennis P. Fitzgibbons was
checking his e-mail at home. A few days earlier, Fitzgibbons'
boss, House Commerce Committee ranking Democrat, John D. Dingell
of Michigan, had asked the General Accounting Office to conduct a
study of the increasing availability of prescription drugs over
the Internet.
So there Fitzgibbons was, scanning his e-mail, only to
find two messages advertising a Web site where anyone could
purchase the anti-impotence drug Viagra without bothering to see
a doctor. As he clicked through the site, Fitzgibbons was
hammered with disclaimers and liability releases such as: ''I
understand the side effects of this drug . . . '' and ''I certify
that I will answer all questions truthfully.'' Yet nowhere did
the Web site disclose Viagra's possible side effects--indeed, the
only real warning is a suggestion that the consumer answer
questions truthfully because ''your medical history informs us of
any possible medical contraindications.''
Finally he was prompted to give his name, phone number,
and credit card number. And though Fitzgibbons was told by the
Web site that a doctor would review his questionnaire, the end of
the application noted that processing ''may take up to two
minutes.'' And, indeed, within a couple of minutes, Fitzgibbons
received an OK. Though he didn't order the pills, he was
disturbed at how easily he could have. ''It was a Sunday
morning--I'd be very surprised if there was a physician sitting
there'' reviewing his application, he said. ''It seemed to
suggest to me that your virtual physician is a virtual quack.''
Fitzgibbons' experience underlines the fact that it is
getting easier and easier for Americans to buy any kind of
medicine on the Internet, often without a prescription, and with
no one really in charge of regulating the online market.
''This is the future,'' says Michael Gury, a spokesman at
IMS Health, the world's leading provider of information systems
to the pharmaceutical industry. ''The Internet has just taken
everybody by storm.'' Jupiter Communications, a New York City-
based research company, estimates that $ 66 million worth of all
health and beauty products will be sold online in 1999; by 2002,
sales could reach $ 1.2 billion.
Hoping to get a handle on online drug sales, Fitzgibbons
was part of a recent government powwow conducted by the House
Commerce Committee, where he is minority deputy staff director.
Because the Justice Department, the Federal Trade Commission, and
the Food and Drug Administration have overlapping authority over
drug sales, officials from all three agencies attended the
gathering to discuss who should regulate the sale of drugs on the
Internet. The FDA has primary federal jurisdiction, a Justice
spokesman said, but Justice's Office of Consumer Litigation
prosecutes criminal violations of the Food, Drug, and Cosmetics
Act and the department's Drug Enforcement Administration has
jurisdiction over violations of laws that cover controlled
substances. The FTC has jurisdiction over Internet drug sales
only when deception or misrepresentation is involved.
Drug sales in cyberspace are so new, but growing so fast,
that government and industry representatives are still struggling
to assess the scope of the Internet drug bazaar and its
implications. ''What we want to do is figure out which online
pharmacies are questionable and which are appropriate,'' said
Jeff Trewhitt, a spokesman for the Pharmaceutical Research and
Manufacturers of America, which represents major drug companies.
''We strongly believe that anything that circumvents the
traditional physician-patient relationship is dangerous.''
But there's nothing traditional about the increasingly
eclectic and lucrative Internet drug trade. Web sites such as
drugstore.com (partly owned by Amazon.com Inc.'s founder, Jeff
Bezos) and Riteaid.com require that prescriptions be faxed or
mailed and are regarded by industry observers as reputable. But
plenty of Internet operations aren't widely known and are harder
to assess.
Consider, for instance, Direct Response Marketing, which
has been operating for a year in the British Channel Islands,
selling the anti-baldness drug Propecia, the anti-obesity drug
Xenical, and Viagra, mainly to Americans. Managing Director Tom
O'Brien said in an interview that his company screens patients
with online questionnaires that are ''scrutinized by company
doctors,'' who frequently turn people down, even if they merely
suspect ''that something isn't ringing right. . . . We try to be
as conscientious as we can.'' He entered this business because
''the Internet was such an interesting medium with a global
market and low overhead,'' O'Brien explains.
Customers who use Direct Response Marketing, O'Brien
says, are knowledgeable and sophisticated about what they want.
''We don't solicit anybody. People have to be aware that the drug
exists and come to us. We're not talking about vulnerable or
gullible people. These are people who know how to use a search
engine and know they want to use a certain drug.''
Carmen Catizone, executive director of the National
Association of Boards of Pharmacy, the trade group for
pharmacies, estimates that there are as many as 200 pharmacies
online, plus an unlimited number of other kinds of temporary
sites offering prescription drugs. ''One site will serve as a
shell, and as many as 20 or 30 other sites will feed off of it
with a series of hyperlinks. This provides a way of avoiding
detection. There is almost no accountability, because when you go
back, a link that was there may have disappeared.''
Catizone's group recently announced that it's developing
a seal of approval for online pharmacies to help customers
determine which are legitimate operations. Doctors say such a
step is necessary.
''We have been monitoring the situation carefully,'' says
Juhana Idanpaan-Heikkila, the director of drug management and
policies at the World Health Organization. ''Before Viagra was
officially approved anywhere in the world, it was available on
the Internet. . . . No prescriptions were required.'' Pfizer
Inc., which makes Viagra, found 270,000 Web sites promoting or
selling the potency drug, Idanpaan-Heikkila said, and ''one of
their executives told me that they don't have the resources to
control the situation.'' WHO has created an online guide with
instructions on finding reliable medical information and
assistance on the World Wide Web.
But at the federal level, little is being done to curb
any abuses. FDA spokesman Brad Stone said the agency is concerned
about ''anything that short-circuits the traditional physician-
patient relationship,'' but the FDA has power only over the drug
products and how they are marketed, not the doctor-patient
relationship. ''If you are selling a drug over the Internet, you
need to use a legal prescription process, but the determination
of what qualifies as a legal process rests with the state medical
boards.''
But ask FDA officials to guess the scope of the problem
and--like everyone else--they're clueless. Because the Internet
is so sprawling, ''it's hard for us to have a definitive number
for how many illegal drugs are sold over the Web,'' Stone says.
''We just don't know.''
In the vastness of cyberspace, anonymity is so easy to
achieve that a certain level of anarchy and lawbreaking prevails.
Add to this the uncertainty about which government agency is
responsible for the online drug trade, and things get even
murkier. And all of the legitimate dispensing of prescriptions
that takes place on the Web makes it even harder to isolate the
transactions that are illegitimate.
So, who should patrol these online drugstores? Both the
FDA and the American Medical Association describe state medical
boards as ''ideal'' regulators. The AMA considers the issue to be
so important that its board of trustees will issue a report on
the problem at its annual meeting this month. The AMA believes
Internet drugstores are ''a growing concern,'' one of the
trustees, Donald J. Palmisano, said. ''The existence of a
patient-physician relationship is a prerequisite for prescribing.
We want to discuss the definition of that relationship in light
of new technologies to see if there needs to be any
clarification.''
Dingell has led the congressional effort to investigate
the Internet drug trade. He has specifically asked the GAO to
examine whether online companies fall short in verifying
prescriptions, and if they do, how often. ''We've been concerned
for a long time about how Internet commerce would affect a number
of laws--pharmaceuticals, firearms, controlled substances,'' he
says. ''Regarding pharmaceuticals, we've looked at a number of
areas--how is the doctor-patient relationship being honored? Are
the necessary steps being taken to ensure patient safety?''
Dingell mentioned a female journalist he knows who ordered Viagra
online for herself and for her cat. She dropped a letter from her
own name--and added a surname to the cat's name--so they would
seem to be men. ''She didn't specify her gender,'' he notes.
''They never bother to ask any questions at all. If one person
can set up that kind of peculiar situation, it's clear to me that
there are other smart people around who can do it too.''